Mechanisms of angiotensin II signaling on cytoskeleton of podocytes

[1]  D. Ganten,et al.  Update on tissue renin–angiotensin systems , 2008, Journal of Molecular Medicine.

[2]  H. Kawachi,et al.  Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. , 2007, The American journal of pathology.

[3]  Jérémie Rossy,et al.  Ezrin/moesin in motile Walker 256 carcinosarcoma cells: signal-dependent relocalization and role in migration. , 2007, Experimental cell research.

[4]  K. Sunagawa,et al.  Pressor response induced by central angiotensin II is mediated by activation of Rho/Rho-kinase pathway via AT1 receptors , 2007, Journal of hypertension.

[5]  D. Ingber,et al.  α-Actinin-4 Is Required for Normal Podocyte Adhesion* , 2007, Journal of Biological Chemistry.

[6]  M. Cotton,et al.  Endogenous ARF6 interacts with Rac1 upon angiotensin II stimulation to regulate membrane ruffling and cell migration. , 2006, Molecular biology of the cell.

[7]  K. Griendling,et al.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.

[8]  D. Kwiatkowski,et al.  Requirement of Rac1 in the development of cardiac hypertrophy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Tryggvason,et al.  Nck Links Nephrin to Actin in Kidney Podocytes , 2006, Cell.

[10]  G. Remuzzi,et al.  Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention. , 2006, The American journal of pathology.

[11]  H. Pavenstädt,et al.  Functional expression of the renin-angiotensin system in human podocytes. , 2006, American journal of physiology. Renal physiology.

[12]  G. Remuzzi,et al.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. , 2006, The Journal of clinical investigation.

[13]  Ying Wang,et al.  Ezrin/Radixin/Moesin Proteins Are Phosphorylated by TNF-α and Modulate Permeability Increases in Human Pulmonary Microvascular Endothelial Cells1 , 2006, The Journal of Immunology.

[14]  M. Osanai,et al.  Phosphorylation of ezrin enhances microvillus length via a p38 MAP-kinase pathway in an immortalized mouse hepatic cell line. , 2006, Experimental cell research.

[15]  S. Shankland,et al.  Podocyte injury and targeting therapy: an update , 2006, Current opinion in nephrology and hypertension.

[16]  T. Benzing,et al.  Expression and function of C/EBP homology protein (GADD153) in podocytes. , 2006, The American journal of pathology.

[17]  J. Pitcher,et al.  G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton. , 2005, Molecular biology of the cell.

[18]  M. Farquhar,et al.  Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. , 2004, Journal of the American Society of Nephrology : JASN.

[19]  Harry Holthöfer,et al.  Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. , 2004, Kidney international.

[20]  N. Gretz,et al.  J Am Soc Nephrol 15: 1475–1487, 2004 Angiotensin II Type 1 Receptor Overexpression in Podocytes Induces Glomerulosclerosis in Transgenic Rats , 2022 .

[21]  E. Fleck,et al.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease , 1996, Journal of Molecular Medicine.

[22]  T. Takeda.  Podocyte cytoskeleton is connected to the integral membrane protein podocalyxin through Na+/H+-exchanger regulatory factor 2 and ezrin , 2003, Journal of Clinical and Experimental Nephrology.

[23]  R. Gerszten,et al.  Mice deficient in α-actinin-4 have severe glomerular disease , 2003 .

[24]  R. Gerszten,et al.  Mice deficient in alpha-actinin-4 have severe glomerular disease. , 2003, The Journal of clinical investigation.

[25]  Matthias Kretzler,et al.  Cell biology of the glomerular podocyte. , 2003, Physiological reviews.

[26]  P. Seshiah,et al.  Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators , 2002, Circulation research.

[27]  A. Bretscher,et al.  ERM proteins and merlin: integrators at the cell cortex , 2002, Nature Reviews Molecular Cell Biology.

[28]  Stacy L DeRuiter,et al.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Y. Pinto,et al.  Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy , 2001, Journal of Molecular Medicine.

[30]  M. Farquhar,et al.  Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. , 2001, The Journal of clinical investigation.

[31]  James Monypenny,et al.  Ezrin is a downstream effector of trafficking PKC–integrin complexes involved in the control of cell motility , 2001, The EMBO journal.

[32]  A. Schwarz,et al.  New aspects of the treatment of nephrotic syndrome. , 2001, Journal of the American Society of Nephrology : JASN.

[33]  J. Kaplan,et al.  Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis , 2000, Nature Genetics.

[34]  J. Kaplan,et al.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. , 2000, Nature genetics.

[35]  J. Gloy,et al.  Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus. , 2000, Kidney international.

[36]  D. Trono,et al.  A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.

[37]  K. Rahn,et al.  Effects of Diadenosine Polyphosphates on the Intracellular Ca2+ Concentration in Endothelial Cells , 1998, Cellular Physiology and Biochemistry.

[38]  T. Shimada,et al.  Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cells. , 1998, Human gene therapy.

[39]  P. Mundel,et al.  Regulation of podocyte structure during the development of nephrotic syndrome , 1998, Journal of Molecular Medicine.

[40]  K. Kaibuchi,et al.  Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail Association , 1998, The Journal of cell biology.

[41]  H. Pavenstädt,et al.  Angiotensin II increases the cytosolic calcium activity in rat podocytes in culture. , 1997, Kidney international.

[42]  J. Gloy,et al.  Angiotensin II depolarizes podocytes in the intact glomerulus of the Rat. , 1997, The Journal of clinical investigation.

[43]  Y Wanaka,et al.  [Angiotensin II]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.

[44]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[45]  M. Caron,et al.  Inhibition of the beta-adrenergic receptor kinase by polyanions. , 1989, The Journal of biological chemistry.

[46]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[47]  D. Baltimore,et al.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus , 1983, Cell.